Neumora Therapeutics, Inc.

NMRA · XNAS

CIK 1885522fmd_1H02YV34X97HKQCQP7G97N5VFVManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2022 to Jun 30, 2026, 18 periods

Event typeImportance0 filings

From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).